Aspiriant LLC’s Paychex PAYX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$734K Sell
7,454
-4,985
-40% -$577K 0.02% 207
2026
Q2
$1.22M Buy
12,439
+1,332
+12% +$126K 0.03% 158
2026
Q1
$1.02M Sell
11,107
-10
-0.1% -$989 0.03% 152
2025
Q4
$1.25M Sell
11,117
-130
-1% -$15.2K 0.04% 146
2025
Q3
$1.43M Sell
11,247
-50
-0.4% -$6.94K 0.04% 123
2025
Q2
$1.64M Sell
11,297
-24
-0.2% -$3.61K 0.05% 115
2025
Q1
$1.75M Buy
11,321
+27
+0.2% +$3.97K 0.06% 101
2024
Q4
$1.58M Sell
11,294
-385
-3% -$54.7K 0.06% 109
2024
Q3
$1.57M Sell
11,679
-201
-2% -$25.5K 0.06% 108
2024
Q2
$1.41M Sell
11,880
-515
-4% -$62.9K 0.06% 107
2024
Q1
$1.52M Hold
12,395
– – 0.06% 111
2023
Q4
$1.48M Buy
12,395
+242
+2% +$28.7K 0.07% 111
2023
Q3
$1.4M Buy
12,153
+20
+0.2% +$2.41K 0.07% 109
2023
Q2
$1.36M Buy
12,133
+19
+0.2% +$2.08K 0.07% 106
2023
Q1
$1.39M Buy
12,114
+35
+0.3% +$3.98K 0.07% 104
2022
Q4
$1.4M Buy
12,079
+7
+0.1% +$819 0.07% 102
2022
Q3
$1.36M Sell
12,072
-11
-0.1% -$1.36K 0.07% 99
2022
Q2
$1.38M Sell
12,083
-13
-0.1% -$1.63K 0.07% 101
2022
Q1
$1.65M Buy
12,096
+152
+1% +$18.7K 0.09% 96
2021
Q4
$1.63M Buy
11,944
+381
+3% +$47.1K 0.09% 101
2021
Q3
$1.3M Sell
11,563
-259
-2% -$29.1K 0.08% 102
2021
Q2
$1.27M Buy
11,822
+459
+4% +$46.2K 0.07% 97
2021
Q1
$1.11M Buy
11,363
+328
+3% +$30.2K 0.07% 97
2020
Q4
$1.03M Sell
11,035
-4,190
-28% -$372K 0.07% 98
2020
Q3
$1.22M Buy
15,225
+4,171
+38% +$313K 0.1% 89
2020
Q2
$838K Sell
11,054
-139
-1% -$9.6K 0.08% 96
2020
Q1
$705K Sell
11,193
-180
-2% -$14.4K 0.07% 102
2019
Q4
$966K Sell
11,373
-240
-2% -$20.2K 0.09% 99
2019
Q3
$961K Buy
+11,613
New +$965K 0.09% 109
2018
Q4
– Sell
-2,788
Closed -$207K – 246
2018
Q3
$207K Sell
2,788
-524
-16% -$37.7K 0.02% 224
2018
Q2
$226K Sell
3,312
-1,065
-24% -$68.7K 0.02% 230
2018
Q1
$270K Buy
+4,377
New +$289K 0.02% 204
2017
Q4
– Sell
-6,466
Closed -$388K – 146
2017
Q3
$388K Sell
6,466
-872
-12% -$49.8K 0.03% 149
2017
Q2
$418K Sell
7,338
-20
-0.3% -$1.17K 0.04% 152
2017
Q1
$433K Sell
7,358
-2,664
-27% -$162K 0.04% 154
2016
Q4
$610K Buy
10,022
+282
+3% +$16.2K 0.06% 129
2016
Q3
$564K Sell
9,740
-9,187
-49% -$551K 0.06% 132
2016
Q2
$887K Buy
18,927
+8,589
+83% +$460K 0.08% 109
2016
Q1
$558K Buy
+10,338
New +$521K 0.05% 130

Other funds holding PAYX

Aspiriant LLC's PAYX Position: Q3 2026 in Review

Aspiriant LLC reduced its Paychex (PAYX) stake by 40% in Q3 2026, selling an estimated $577K and leaving 7,454 shares worth $734K. The position accounts for 0.02% of the portfolio, ranked #207.

Aspiriant LLC first reported a position in PAYX in Q1 2016 and has held it in 39 quarters since. The position peaked at $1.75M in Q1 2025. 1,358 funds tracked by Wall St. Rank hold PAYX as of Q3 2026.

  • Aspiriant LLC held 7,454 shares of Paychex worth $734K as of Q3 2026.
  • Aspiriant LLC sold 4,985 Paychex shares in Q3 2026, an estimated $577K.
  • Paychex made up 0.02% of Aspiriant LLC's portfolio in Q3 2026, its #207 holding.
  • Aspiriant LLC first reported a position in Paychex in Q1 2016 and has held it in 39 quarters since.
  • Aspiriant LLC's Paychex position peaked at $1.75M in Q1 2025.
  • 1,358 funds tracked by Wall St. Rank held Paychex as of Q3 2026.

Based on Aspiriant LLC's 13F filing for Q3 2026, filed 16 Oct 2026.